Dyne is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. 

Biotechnology

Dyne Therapeutics

Dyne Therapeutics' headquarters in Cambridge, MA, United States

The Waltham office focuses on clinical development, regulatory affairs, and scientific research in biotechnology and pharmaceuticals.

Waltham

Robert Ciamarra

Lucia Celona

Oxana Beskrovnaya

Daniel Wilson

Clarence J. Wang

Kate Mitchell

Debra Feldman

Ross Hanson

Iva Ivanovska Holder

Jessica Vozella

Erick J. Lucera

David Yered

Michael Tobin

Ann Marie Curatolo

Tammy Gauthier Wilson

Eric Golovchenko

Vinita Leslie

Chui-Se Tham

Molly White

Joanne Bryce

Baoguang Han

Brian Newkirk

Kelly Comma

Director, Clinical Pharmacology And Pharmacometrics

Shekhar Natarajan Msc Frsc Ftopra

Ashley Clark

Jasvir Bahia

Sven Loebrich

Ivan Soto

Thomas Natoli

Cody Desjardins

Vinod Yadav

Suhas Bhat Mulki

Andrew Campbell

Derek Bagozzi

Anne Lise Almira

Emily Cozzi

Suma Yaddanapudi

Zachary E. Hurwitz

Jeffrey Ellis

Annalyn Gilchrist

Emily Gainor

Frank Smith

Cong Yao

Gosia Pawlikowska

Benn Waters

Caleb Bliss

Ajay Parmar

Ramin Dehghanpoor

Timothy Swan

Marco Fontana

Sarah Farina

Brian Jochim

Ronald Caponigro

Nicole Hartley Ms

Lori Ryan

David Lubner

Jason Rhodes

Ed Hurwitz

Catherine Stehman-Breen

Carlo Incerti

Dirk Kersten

The Clinical and Research Team at Dyne Therapeutics is dedicated to advancing innovative therapeutics for patients with genetically driven muscle diseases. This team conducts and oversees clinical trials, spearheads scientific research, coordinates preclinical development, manages clinical data, and ensures regulatory compliance. They collaborate across disciplines to translate scientific discoveries into effective treatments, with a focus on clinical development, pharmacovigilance, medical writing, and international medical science liaison.


Clinical and Research Team

This department oversees the development and management of clinical operations, regulatory affairs, and medical affairs to ensure compliance and effective execution of clinical trials.

Clinical Operations and Affairs

The Leadership Team at Dyne Therapeutics is responsible for setting the strategic direction of the company, overseeing operations, and ensuring alignment across all departments to advance innovative therapeutics for muscle diseases. This cross-functional team, comprised of executives from corporate communications, regulatory affairs, technology, business development, human resources, patient advocacy, finance, and scientific and medical leadership, collaborates to drive growth, foster partnerships, and enhance stakeholder engagement, all while prioritizing patient needs and regulatory compliance.

Leadership Team

This department oversees the development and implementation of quality assurance protocols and standards to ensure product integrity and compliance.

Quality Assurance

The Regulatory and Compliance Team at Dyne Therapeutics ensures that all company activities adhere to legal standards, regulatory requirements, and industry best practices. They manage external reporting, intellectual property, contracts, pharmacovigilance operations, and regulatory affairs to support the development and commercialization of innovative therapeutics for muscle diseases.

Regulatory and Compliance Team

This department oversees strategic direction and governance for the organization.

Executive Leadership

Dyne Therapeutics

Org chart

Board & advisors

Teams

Clinical and Research Team

Clinical Operations and Affairs

Leadership Team

Quality Assurance

Regulatory and Compliance Team

Executive Leadership

Offices

Dyne Therapeutics

Org chart

Board & advisors

Teams

Clinical and Research Team

Clinical Operations and Affairs

Leadership Team

Quality Assurance

Regulatory and Compliance Team

Executive Leadership

Offices

Related companies